3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.

Saved in:
Bibliographic Details
Title: 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
Authors: Porsbjerg C; Dept of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen, Denmark celeste.porsbjerg@regionh.dk.; Copenhagen Center for Translational Research, Bispebjerg Hospital, Copenhagen, Denmark., Maitland-van der Zee AH; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Dept of Pediatric Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Brusselle G; Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium., Canonica GW; Personalized Medicine, Asthma and Allergy Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.; Dept of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Agusti A; Hospital Clinic, University of Barcelona, Barcelona, Spain.; IDIBAPS, CIBERES, Barcelona, Spain., Faner R; Hospital Clinic, University of Barcelona, Barcelona, Spain., Vogelmeier CF; Dept of Medicine, Pulmonary and Critical Care Medicine, University of Marburg (UMR), Marburg, Germany.; Member of the German Center for Lung Research (DZL), Marburg, Germany., Nawijn M; Dept of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands., van den Berge M; Dept of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Rusconi F; Unit of Epidemiology, Meyer Children's University Hospital, Florence, Italy., Pilette C; Dept of pneumology, Cliniques universitaires Saint-Luc and Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium., Ramiconi V; European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium., Coleman C; European Lung Foundation, Sheffield, UK., Chaudhuri R; Division of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Chung KF; National Heart and Lung Institute, Imperial College London, London, UK., Wedzicha J; National Heart and Lung Institute, Imperial College London, London, UK., Saglani S; National Heart and Lung Institute, Imperial College London, London, UK.; Dept of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK., Van der Schee MP; Owlstone Medical Ltd, Cambridge, UK., Heaney L; Wellcome-Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK., Bourdin A; Dept of Respiratory Diseases, Univ Montpellier, CHU Montpellier, Montpellier, France.; PhyMedExp, Univ Montpellier, CNRS, INSERM, Montpellier, France., Roberts G; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UK., Djukanovic R; Clinical and Experimental Science, Faculty of Medicine and NIHR Southampton Biomedical Research centre, Southampton, UK., Kuna P; Dept of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland., Kupczyk M; Dept of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland., Axmann J; Immunology, Infectious Diseases and Ophthalmology Discovery and Translational Area, Roche Pharma Research & Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Staudinger H; Clinical Strategy Lead, Immunology and Inflammation Therapeutic Area, Sanofi Genzyme, Bridgewater, NJ, USA., Clarke GW; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Dahlen SE; The Center for Allergy Research and the Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Dept of Respiratory Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden., Brightling C; Dept of Respiratory Sciences, University of Leicester, Leicester, UK.
Source: The European respiratory journal [Eur Respir J] 2021 Oct 21; Vol. 58 (4). Date of Electronic Publication: 2021 Oct 21 (Print Publication: 2021).
Publication Type: Editorial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1399-3003
DOI:10.1183/13993003.02168-2021